🇺🇸 FDA

Company profile · Sponsor

Taiwan

Taiwan Liposome Company

C4F1476 · NMPA pharma CN
Pipeline
6
Drugs
0
Patents
0

Quick answer

Taiwan (C4F1476) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 6 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker C4F1476
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (6)

Search pipeline →

  1. Cyclophosphamide Doxorubicin Vincristine Lamivudine

    Taiwan

    Non-Hodgkin's Lymphoma

    phase 2 small molecule completed

    1 trial

  2. Lipotecan

    Taiwan

    HepatoCellular Carcinoma

    phase 2 small molecule terminated

    1 trial

  3. BEL-X-HG

    Taiwan

    Advanced Solid Tumors

    phase 1 small molecule terminated

    1 trial

  4. Ga68-Dolacga Injection

    Taiwan

    Safety Issues

    phase 1 small molecule completed

    1 trial

  5. Lipotecan

    Taiwan

    Advanced Solid Tumors

    phase 1 small molecule completed

    1 trial

  6. Magnesium Citrate

    Taiwan

    Cognitive Function

    other completed

    1 trial

Frequently asked questions

What is Taiwan?

Taiwan (C4F1476) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 6 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Taiwan sponsor?

We track 6 ClinicalTrials.gov-linked programs for Taiwan, including Cyclophosphamide Doxorubicin Vincristine Lamivudine and 5 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Taiwan company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.